Skip to main content
Signal8

Halstead Michael

SEC insider (Form 3/4/5 filer). CIK 0001521548. Chief Executive Officer at CYBIN INC. (CYBN) and 1 other issuer. 20 reported Form 4/5 transactions since Sep 2024; latest on Sep 21, 2026. Located in TORONTO.

Companies Halstead Michael has filed insider reports for

  • CYBIN INC. (CYBN): Officer, Chief Executive Officer
  • Intra-Cellular Therapies, Inc. (ITCI): Officer, President
Halstead Michael profile photo

Halstead Michael

CIK: 0001521548

Transaction Breakdown

Open Market Buys (P)1 (5.0%)

High conviction signal

Open Market Sales (S)5 (25.0%)

Position reduction

Option Exercises (M)5 (25.0%)

Derivative conversions

Awards (A)4 (20.0%)

Compensation grants

Other (G, F, J, C, D, …)5 (25.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (2)

CYBIN INC. logo
CYBN

CYBIN INC.

Officer
Intra-Cellular Therapies, Inc. logo
ITCI

Intra-Cellular Therapies, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (20 total)

  • CYBIN INC. logo
    CYBN

    CYBIN INC.

    Sep 21, 2026
    Purchase
    Direct
    100K shares at avg. $13.47$1.3M
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Award

    Performance Stock Units

    Direct
    13.1K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Disposition
    Direct
    21.3K shares at avg. $132.00$2.8M
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Apr 2, 2025
    Award

    Performance Stock Units

    Direct
    12.2K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 10, 2025
    Tax Payment
    Direct
    3.8K shares at avg. $131.24$493K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 10, 2025
    Exercise
    Direct
    7.3K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 6, 2025
    Exercise
    Direct
    13.1K shares-
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 6, 2025
    Tax Payment
    Direct
    6.7K shares at avg. $131.19$881K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 1, 2025
    Tax Payment
    Direct
    6.3K shares at avg. $128.20$803K
  • Intra-Cellular Therapies, Inc. logo
    ITCI

    Intra-Cellular Therapies, Inc.

    Mar 1, 2025
    Exercise
    Direct
    12.2K shares-

1-10 of 20